A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps

References

• National Research Council 2011. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. (WA) DC: The National Academies Press; 2011.
   Google Scholar
• Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17:507–522.
   PubMed Web of Science ®Google Scholar
• Agache I, Akdis CA. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Invest. 2019;129:1493–1503.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95.
   PubMed Web of Science ®Google Scholar
• Mersha TB, Afanador Y, Johansson E, et al. Resolving clinical phenotypes into endotypes in allergy: molecular and omics approaches. Clin Rev Allergy Immunol. 2021;60:200–219.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464.
   Web of Science ®Google Scholar
• Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11:213–739.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Asaka D, Yoshikawa M, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis. Am J Rhinol Allergy. 2012;26:172–176.
   PubMed Web of Science ®Google Scholar
• Soler ZM, Hyer JM, Ramakrishnan V, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis. Int Forum Allergy Rhinol. 2015;5:399–407.
   PubMed Web of Science ®Google Scholar
• Lou H, Meng Y, Piao Y, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps. Rhinology. 2016;54:150–159.
   PubMed Web of Science ®Google Scholar
• Soler ZM, Hyer JM, Rudmik L, et al. Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis. J Allergy Clin Immunol. 2016;137:1054–1062.
   PubMed Web of Science ®Google Scholar
• Tomassen P, Vandeplas G, Zele TV, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137:1449–1456.
   PubMed Web of Science ®Google Scholar
• Stevens WW, Peters AT, Tan BK, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7:2812–2820.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Lee IT, Le W, et al. Inflammatory molecular endotypes of nasal polyps derived from White and Japanese populations. J Allergy Clin Immunol. 2022;149:1296–1308.
   PubMed Web of Science ®Google Scholar
• Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107–1119.
   PubMed Web of Science ®Google Scholar
• Jankowski R, Bouchoua F, Coffinet L, et al. Clinical factors influencing the eosinophil infiltration of nasal polyps. Rhinology. 2002;40:173–178.
   PubMed Web of Science ®Google Scholar
• Soler ZM, Sauer D, Mace J, et al. Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery. Otolaryngol Head Neck Surg. 2010;142:64–71.
   PubMed Web of Science ®Google Scholar
• Vlaminck S, Vauterin T, Hellings PW, et al. The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis: a 3-year prospective observational study. Am J Rhinol Allergy. 2014;28:260–264.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016;138:1344–1353.
   PubMed Web of Science ®Google Scholar
• Cao PP, H-B L, Wang B-F, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124:478–484.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Yoshikawa M, Asaka D, et al. Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis. Rhinology. 2011;49:392–396.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee KH, Kim SW, et al. Changes in histological features of nasal polyps in a Korean population over a 17‐year period. Otolaryngol Head Neck Surg. 2013;149:431–437.
   PubMed Web of Science ®Google Scholar
• Klingler AI, Stevens WW, Tan BK, et al. Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol. 2021;147:1306–1317.
   PubMed Web of Science ®Google Scholar
• Delemarre T, Holtappels G, Ruyck ND, et al. Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype. J Allergy Clin Immunol. 2020;146:337–343.
   PubMed Web of Science ®Google Scholar
• Lou H, Zhang N, Bachert C, et al. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018;8:1218–1225.
   PubMed Web of Science ®Google Scholar
• Haruna S, Otori N, Yanagi K, et al. Eosinophilic sinusitis. Oto-Rhino-Laryngology Tokyo. 2001;44:195–201.
   Google Scholar
• Takeno S, Hirakawa K, Ishino T. Pathological mechanisms and clinical features of eosinophilic chronic rhinosinusitis in the Japanese population. Allergol Int. 2010;59:247–256.
   PubMedGoogle Scholar
• Ishitoya J, Sakuma Y, Tsukuda M. Eosinophilic chronic rhinosinusitis in Japan. Allergol Int. 2010;59:239–245.
   PubMedGoogle Scholar
• Newman LJ, Platts-Mills TAE, Phillips CD, et al. Chronic Sinusitis: relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA. 1994;271:363–367.
   PubMed Web of Science ®Google Scholar
• Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope. 2000;110:799–813.
   PubMed Web of Science ®Google Scholar
• Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol. 2004;12:237–242.
   PubMedGoogle Scholar
• Grayson JW, Hopkins C, Mori E, et al. Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngology Head Neck Surg. 2020;146:831–838.
   PubMed Web of Science ®Google Scholar
• Kim J-W, Hong S-L, Kim Y-K, et al. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg. 2007;137:925–930.
   PubMed Web of Science ®Google Scholar
• Soler ZM, Sauer DA, Mace J, et al. Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2009;141:454–461.
   PubMed Web of Science ®Google Scholar
• Bonfils P, Badoual C, Bonfils NA, et al. Eosinophil infiltration of nasal polyps in patients with nasal polyposis: role in clinical evolution after medical and surgical treatment. J Laryngol Otol. 2008;123:509–516.
   PubMed Web of Science ®Google Scholar
• Soy FK, Pinar E, Imre A, et al. Histopathologic parameters in chronic rhinosinusitis with nasal polyposis: impact on quality of life outcomes. Int Forum Allergy Rhinol. 2013;3:828–833.
   PubMed Web of Science ®Google Scholar
• Brescia G, Marioni G, Franchella S, et al. Can a panel of clinical, laboratory, and pathological variables pinpoint patients with sinonasal polyposis at higher risk of recurrence after surgery? Am J Otolaryngol. 2015;36:554–558.
   PubMed Web of Science ®Google Scholar
• Brescia G, Marioni G, Franchella S, et al. A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2016;273:655–660.
   PubMed Web of Science ®Google Scholar
• Rosati D, Rosato C, Pagliuca G, et al. Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps. Am J Otolaryngol. 2020;41:102286.
   PubMed Web of Science ®Google Scholar
• Snidvongs K, Lam M, Sacks R, et al. Structured histopathology profiling of chronic rhinosinusitis in routine practice. Int Forum Allergy Rhinol. 2012;2:376–385.
   PubMed Web of Science ®Google Scholar
• Barham HP, Osborn JL, Snidvongs K, et al. Remodeling changes of the upper airway with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2015;5:565–572.
   PubMed Web of Science ®Google Scholar
• Kountakis SE, Arango P, Bradley D, et al. Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope. 2004;114:1895–1905.
   PubMed Web of Science ®Google Scholar
• Matsuwaki Y, Ookushi T, Asaka D, et al. Chronic rhinosinusitis: risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery. Int Arch Allergy Immunol. 2008;146:77–81.
   PubMed Web of Science ®Google Scholar
• Hu Y, Cao P, Liang G, et al. Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults. Laryngoscope. 2012;122:498–503.
   PubMed Web of Science ®Google Scholar
• Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol. 2012;129:1522–1528.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Shiozawa A, Ono N, et al. Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil. Laryngoscope. 2013;123:E1–9.
   PubMed Web of Science ®Google Scholar
• Mori E, Matsuwaki Y, Mitsuyama C, et al. Risk factors for olfactory dysfunction in chronic rhinosinusitis. Auris Nasus Larynx. 2013;40:465–469.
   PubMed Web of Science ®Google Scholar
• Grgić MV, Ćupić H, Kalogjera L, et al. Surgical treatment for nasal polyposis: predictors of outcome. Eur Arch Otorhinolaryngol. 2015;272:3735–3743.
   PubMed Web of Science ®Google Scholar
• Tokunaga T, Sakashita M, Haruna T, et al. Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy. 2015;70:995–1003.
   PubMed Web of Science ®Google Scholar
• Lou H, Meng Y, Piao Y, et al. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population. Am J Rhinol Allergy. 2015;29:350–356.
   PubMed Web of Science ®Google Scholar
• Wang K, Deng J, Yang M, et al. Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps. World Allergy Organization J. 2019;12:100052.
   PubMed Web of Science ®Google Scholar
• Pan L, Liao B, Guo C, et al. Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia. Int Forum Allergy Rhinol. 2021;11:846–856.
   PubMed Web of Science ®Google Scholar
• McHugh T, Snidvongs K, Xie M, et al. High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta‐analysis. Int Forum Allergy Rhinol. 2018;8:1421–1429.
   PubMed Web of Science ®Google Scholar
• Gurrola J, Borish L. Chronic rhinosinusitis: endotypes, biomarkers, and treatment response. J Allergy Clin Immunol. 2017;140:1499–1508.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chen J, Deng H, et al. Expert-level diagnosis of nasal polyps using deep learning on whole-slide imaging. J Allergy Clin Immunol. 2020;145:698–701.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chen J, Ren Y, et al. Artificial intelligence for cellular phenotyping diagnosis of nasal polyps by whole-slide imaging. EBioMedicine. 2021;66:103336.
   PubMed Web of Science ®Google Scholar
• Paoletti G, Malvezzi L, Riccio AM, et al. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps. World Allergy Organization J. 2022;15:100700.
   PubMed Web of Science ®Google Scholar
• Ueki S, Konno Y, Takeda M, et al. Eosinophil extracellular trap cell death–derived DNA traps: their presence in secretions and functional attributes. J Allergy Clin Immunol. 2016;137:258–267.
   PubMed Web of Science ®Google Scholar
• Persson EK, Verstraete K, Heyndrickx I, et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science. 2019;364:eaaw4295.
   PubMed Web of Science ®Google Scholar
• Neves VH, Palazzi C, Bonjour K, et al. In Vivo ETosis of human eosinophils: the ultrastructural signature captured by TEM in eosinophilic diseases. Front Immunol. 2022;13:938691.
   PubMed Web of Science ®Google Scholar
• Chen W, Bai Y, Kong W, et al. Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence. Clin Transl Allergy. 2022;12:e12212.
   PubMed Web of Science ®Google Scholar
• Zhang N, van ZT, Pérez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122:961–968.
   PubMed Web of Science ®Google Scholar
• Tan BK, Klingler AI, Poposki JA, et al. Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. J Allergy Clin Immunol. 2017;139:699–703.
   PubMed Web of Science ®Google Scholar
• Okada N, Nakayama T, Asaka D, et al. Distinct gene expression profiles and regulation networks of nasal polyps in eosinophilic and non-eosinophilic chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018;8:592–604.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Sugimoto N, Okada N, et al. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps. Auris Nasus Larynx. 2019;46:374–383.
   PubMed Web of Science ®Google Scholar
• Liu C, Yan B, Qi S, et al. Predictive significance of Charcot–Leyden crystals for eosinophilic chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33:671–680.
   PubMed Web of Science ®Google Scholar
• Qi S, Yan B, Liu C, et al. Predictive significance of Charcot-Leyden Crystal mRNA levels in nasal brushing for nasal polyp recurrence. Rhinology. 2020;58:166–174.
   PubMed Web of Science ®Google Scholar
• Izuhara K, Nunomura S, Nanri Y, et al. Periostin: an emerging biomarker for allergic diseases. Allergy. 2019;74:2116–2128.
   PubMed Web of Science ®Google Scholar
• Stankovic KM, Goldsztein H, Reh DD, et al. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin‐sensitive asthma. Laryngoscope. 2008;118:881–889.
   PubMed Web of Science ®Google Scholar
• Ishida A, Ohta N, Suzuki Y, et al. Expression of pendrin periostin in allergic rhinitis chronic rhinosinusitis. Allergol Int. 2012;61:589–595.
   PubMed Web of Science ®Google Scholar
• Gevaert E, Zhang N, Krysko O, et al. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J Allergy Clin Immunol. 2017;139:1849–1860.
   PubMed Web of Science ®Google Scholar
• Ebenezer JA, Christensen JM, Oliver BG, et al. Periostin as a marker of mucosal remodelling in chronic rhinosinusitis. Rhinology. 2017;55:234–241.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang X, Zhang N, et al. Association of periostin expression with eosinophilic inflammation in nasal polyps. J Allergy Clin Immunol. 2015;136:1700–1703.
   PubMed Web of Science ®Google Scholar
• de SE, Derycke L, Calus L, et al. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology. 2017;55:152–160.
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Noguchi E, Haruna T, et al. Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinusitis with nasal polyps. Sci Rep. 2018;8:11450.
   PubMed Web of Science ®Google Scholar
• Kato Y, Takabayashi T, Sakashita M, et al. Expression and functional analysis of CST1 in intractable nasal polyps. Am J Respir Cell Mol Biol. 2018;59:448–457.
   PubMed Web of Science ®Google Scholar
• Yan B, Lou H, Wang Y, et al. Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2019;144:455–469.
   PubMed Web of Science ®Google Scholar
• Yao T, Kojima Y, Koyanagi A, et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope. 2009;119:1053–1059.
   PubMed Web of Science ®Google Scholar
• Walker A, Surda P. Unsupervised learning techniques for the investigation of chronic rhinosinusitis. Ann Otol Rhinol Laryngol. 2019;128:1170–1176.
   PubMed Web of Science ®Google Scholar
• Cardell L-O, Stjärne P, Jonstam K, et al. Endotypes of chronic rhinosinusitis: impact on management. J Allergy Clin Immunol. 2020;145:752–756.
   PubMed Web of Science ®Google Scholar
• Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147:29–36.
   PubMed Web of Science ®Google Scholar
• Bachert C, Akdis CA. Phenotypes and emerging endotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2016;4:621–628.
   PubMed Web of Science ®Google Scholar
• Maxfield AZ, Landegger LD, Brook CD, et al. Periostin as a biomarker for nasal polyps in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2017;158:181–186.
   PubMed Web of Science ®Google Scholar
• Sato T, Ikeda H, Murakami K, et al. Periostin is an aggravating factor and predictive biomarker of eosinophilic chronic rhinosinusitis. Allergol Int. 2023;72:161–168.
   PubMed Web of Science ®Google Scholar
• Wang G, Zheng H, Chen X, et al. Exploration of predictive biomarkers for postoperative recurrence in chronic rhinosinusitis with nasal polyps based on serum multiple-cytokine profiling. Mediators Inflamm. 2022;2022:1061658.
   PubMed Web of Science ®Google Scholar
• Tsuda T, Nishide M, Maeda Y, et al. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145:843–854.
   PubMed Web of Science ®Google Scholar
• Schwitzguébel A-P, Jandus P, Lacroix J-S, et al. Immunoglobulin deficiency in patients with chronic rhinosinusitis: systematic review of the literature and meta-analysis. J Allergy Clin Immunol. 2015;136:1523–1531.
   PubMed Web of Science ®Google Scholar
• Wu D, Yan B, Wang Y, et al. Predictive significance of Charcot-Leyden crystal protein in nasal secretions in recurrent chronic rhinosinusitis with nasal polyps. Int Arch Allergy Immunol. 2021;182:65–75.
   PubMed Web of Science ®Google Scholar
• Wu D, Yan B, Wang Y, et al. Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2019;144:345–348.
   PubMed Web of Science ®Google Scholar
• Wu D, Yan B, Wang Y, et al. Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2021;148:450–460.
   PubMed Web of Science ®Google Scholar
• Steinke JW, Bradley D, Arango P, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis–nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol. 2003;111:342–349.
   PubMed Web of Science ®Google Scholar
• Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria) Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2004;113:277–283.
   PubMed Web of Science ®Google Scholar
• Lazarinis N, Bood J, Gomez C, et al. Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor. J Allergy Clin Immunol. 2018;142:1080–1089.
   PubMed Web of Science ®Google Scholar
• Smith CM, Hawksworth RJ, Thien FC, et al. Urinary leukotriene E4 in bronchial asthma. Eur Respir J. 1992;5:693–699.
   PubMed Web of Science ®Google Scholar
• Bochenek G, Kuschill-Dziurda J, Szafraniec K, et al. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. J Allergy Clin Immunol. 2014;133:98–103.
   PubMed Web of Science ®Google Scholar
• Choby G, O’brien EK, Smith A, et al. Elevated urine leukotriene E4 is associated with worse objective markers in nasal polyposis patients. Laryngoscope. 2021;131:961–966.
   PubMed Web of Science ®Google Scholar
• Thorwarth RM, Scott DW, Lal D, et al. Machine learning of biomarkers and clinical observation to predict eosinophilic chronic rhinosinusitis: a pilot study. Int Forum Allergy Rhinol. 2021;11:8–15.
   PubMed Web of Science ®Google Scholar
• Choby G, Low CM, Levy JM, et al. Urine Leukotriene E4: implications as a Biomarker in Chronic Rhinosinusitis. Otolaryngol Head Neck Surg. 2022;166:224–232.
   PubMed Web of Science ®Google Scholar
• Arnal J, Flores P, Rami J, et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J. 1999;13:307–312.
   PubMed Web of Science ®Google Scholar
• Colantonio D, Brouillette L, Parikh A, et al. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy. 2002;32:698–701.
   PubMed Web of Science ®Google Scholar
• Jeong JH, Yoo HS, Lee SH, et al. Nasal and exhaled nitric oxide in chronic rhinosinusitis with polyps. Am J Rhinol Allergy. 2014;28:e11–16.
   PubMed Web of Science ®Google Scholar
• Frendo M, Hakansson K, Schwer S, et al. Exhaled and nasal nitric oxide in chronic rhinosinusitis patients with nasal polyps in primary care. Rhinology. 2017;56:59–64.
   Web of Science ®Google Scholar
• Liu C, Zheng M, He F, et al. Role of exhaled nasal nitric oxide in distinguishing between chronic rhinosinusitis with and without nasal polyps. Am J Rhinol Allergy. 2017;31:389–394.
   PubMed Web of Science ®Google Scholar
• Delclaux C, Malinvaud D, Chevalier‐bidaud B, et al. Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis. Clin Exp Allergy. 2008;38:1140–1147.
   PubMed Web of Science ®Google Scholar
• Yao Y, Xie S, Yang C, et al. Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis. Eur Arch Otorhinolaryngol. 2017;274:3559–3566.
   PubMed Web of Science ®Google Scholar
• Cannady SB, Batra PS, Leahy R, et al. Signal transduction and oxidative processes in sinonasal polyposis. J Allergy Clin Immunol. 2007;120:1346–1353.
   PubMed Web of Science ®Google Scholar
• Takeno S, Taruya T, Ueda T, et al. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx. 2013;40:458–464.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Takabayashi T, Imoto Y, et al. Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68:225–232.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930.
   PubMed Web of Science ®Google Scholar
• Kristjansson RP, Benonisdottir S, Davidsson OB, et al. A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis. Nat Genet. 2019;51:267–276.
   PubMed Web of Science ®Google Scholar
• Li Z, Zeng M, Deng Y, et al. 15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation. J Allergy Clin Immunol. 2019;144:1228–1241.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Hirota T, Asaka D, et al. A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations. Allergology Int. 2020;69:138–140.
   PubMed Web of Science ®Google Scholar
• Wang K, Ren Y, Ma L, et al. Deep learning‐based prediction of treatment prognosis from nasal polyp histology slides. Int Forum Allergy Rhinol. 2022;1–13. doi:10.1002/alr.23083.
   Web of Science ®Google Scholar
• Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219–1224.
   PubMed Web of Science ®Google Scholar
• Simard M, Madore A-M, Girard S, et al. Polygenic risk score for atopic dermatitis in the Canadian population. J Allergy Clin Immunol. 2020;147:406–409.
   PubMed Web of Science ®Google Scholar